KR830005872A - 경구투약용 인터페론의 제조방법 - Google Patents
경구투약용 인터페론의 제조방법 Download PDFInfo
- Publication number
- KR830005872A KR830005872A KR1019810003034A KR810003034A KR830005872A KR 830005872 A KR830005872 A KR 830005872A KR 1019810003034 A KR1019810003034 A KR 1019810003034A KR 810003034 A KR810003034 A KR 810003034A KR 830005872 A KR830005872 A KR 830005872A
- Authority
- KR
- South Korea
- Prior art keywords
- interferon
- species
- cells
- isolated
- heterologous
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 19
- 102000014150 Interferons Human genes 0.000 title claims 17
- 108010050904 Interferons Proteins 0.000 title claims 17
- 229940079322 interferon Drugs 0.000 title claims 17
- 210000004027 cell Anatomy 0.000 claims 12
- 241000894007 species Species 0.000 claims 10
- 241000124008 Mammalia Species 0.000 claims 7
- 241000283690 Bos taurus Species 0.000 claims 6
- 241000282326 Felis catus Species 0.000 claims 6
- 241000282414 Homo sapiens Species 0.000 claims 6
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 5
- 230000004044 response Effects 0.000 claims 4
- 241000282898 Sus scrofa Species 0.000 claims 3
- 241000283073 Equus caballus Species 0.000 claims 2
- 102000003886 Glycoproteins Human genes 0.000 claims 2
- 108090000288 Glycoproteins Proteins 0.000 claims 2
- 208000004729 Feline Leukemia Diseases 0.000 claims 1
- 102000003996 Interferon-beta Human genes 0.000 claims 1
- 108090000467 Interferon-beta Proteins 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 230000000118 anti-neoplastic effect Effects 0.000 claims 1
- 229940034982 antineoplastic agent Drugs 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 230000001613 neoplastic effect Effects 0.000 claims 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 claims 1
- 208000003154 papilloma Diseases 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 230000004043 responsiveness Effects 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18046480A | 1980-08-22 | 1980-08-22 | |
US180464 | 1988-04-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR830005872A true KR830005872A (ko) | 1983-09-14 |
Family
ID=22660569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019810003034A KR830005872A (ko) | 1980-08-22 | 1981-08-20 | 경구투약용 인터페론의 제조방법 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0058192A1 (it) |
JP (1) | JPS57501236A (it) |
KR (1) | KR830005872A (it) |
WO (1) | WO1982000588A1 (it) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5827694A (en) * | 1982-03-08 | 1998-10-27 | Genentech, Inc. | DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides |
US5831023A (en) * | 1982-11-01 | 1998-11-03 | Genentech, Inc. | Recombinant animal interferon polypeptides |
US4820515A (en) * | 1982-12-13 | 1989-04-11 | Texas A&M University System | Method of using interferon in low dosage to regulate appetite and efficiency of food utilization |
US4497795A (en) * | 1982-12-13 | 1985-02-05 | The Texas A&M University System | Method of regulating appetite and efficiency of food utilization employing interferon |
US4820514A (en) * | 1985-12-30 | 1989-04-11 | Texas A&M University System | Low dosage of interferon to enhance vaccine efficiency |
ZA878295B (en) * | 1986-11-06 | 1988-05-03 | Amarillo Cell Culture Co. Inc. | Treatment of immuno-resistant disease |
CA1320905C (en) * | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
US5017371A (en) * | 1988-01-06 | 1991-05-21 | Amarillo Cell Culture Company, Incorporated | Method for reducing side effects of cancer therapy |
JPH07119501B2 (ja) * | 1988-12-28 | 1995-12-20 | 敏郎 鈴木 | コンクリート支柱材 |
AUPN976596A0 (en) * | 1996-05-09 | 1996-05-30 | Pharma Pacific Pty Ltd | Stimulation of host defence mechanisms |
CA2253971A1 (en) | 1996-05-09 | 1997-11-13 | Pharma Pacific Pty.Ltd. | Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions |
CN1151840C (zh) * | 1996-05-09 | 2004-06-02 | 太平洋制药控股公司 | 干扰素在制备用于治疗哺乳动物肿瘤病的药剂中的应用 |
US6207145B1 (en) | 1997-05-09 | 2001-03-27 | Pharma Pacific Pty Ltd. | Therapeutic applications of high dose interferon |
US6660258B1 (en) | 1997-05-09 | 2003-12-09 | Pharma Pacific Pty Ltd | Oromucosal cytokine compositions and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK485977A (da) * | 1977-11-01 | 1979-05-02 | Ess Foodeksport | Fremgangsmaade til udvinding af et biologisk aktivt materiale fra svineblodfraktioner |
JPS5562024A (en) * | 1978-10-31 | 1980-05-10 | Hayashibara Takeshi | Preventive and remedy for interferon-sensitive disease |
ZA796175B (en) * | 1978-11-24 | 1980-11-26 | Hoffmann La Roche | Purified proteins and process therefor |
-
1981
- 1981-08-18 EP EP81902402A patent/EP0058192A1/en not_active Withdrawn
- 1981-08-18 JP JP56502921A patent/JPS57501236A/ja active Pending
- 1981-08-18 WO PCT/US1981/001103 patent/WO1982000588A1/en unknown
- 1981-08-20 KR KR1019810003034A patent/KR830005872A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
EP0058192A1 (en) | 1982-08-25 |
WO1982000588A1 (en) | 1982-03-04 |
JPS57501236A (it) | 1982-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Scothorne et al. | Cellular changes in lymph nodes and spleen following skin homografting in the rabbit | |
KR830005872A (ko) | 경구투약용 인터페론의 제조방법 | |
Tomac et al. | Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. | |
Whitworth et al. | Transfer of milk prolactin to the plasma of neonatal rats by intestinal absorption | |
US4861757A (en) | Wound healing and bone regeneration using PDGF and IGF-I | |
AU600069B2 (en) | Wound healing and bone regeneration | |
US5019559A (en) | Wound healing using PDGF and IGF-II | |
Nakano et al. | Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats | |
JPH01500901A (ja) | キメラペプチド及びそれを含む組成物 | |
CA2214503A1 (en) | Method for treating tumors | |
JPH09504516A (ja) | トランスフォーミング増殖因子βによる末梢血における造血前駆細胞の増加 | |
Matsumoto et al. | Purification and properties of the melanization and reddish colouration hormone (MRCH) in the armyworm, Leucania separata (Lepidoptera) | |
Beck et al. | Hormonal activation of the insect brain | |
CA2060208C (en) | Wound healing | |
Kupiec-Weglinski et al. | Lymphocyte traffic is modified in vivo by anti-laminin antibody. | |
Herndon et al. | Surgical removal of the cecum and its effect on digestion and growth in rabbits | |
Alexander et al. | Adoptively transferred tumor-infiltrating lymphocytes can cure established metastatic tumor in mice and persist long-term in vivo as functional memory T lymphocytes | |
Daikoku et al. | Ontogenetic appearance of immunoreactive GRF-containing neurons in the rat hypothalamus | |
Zammit et al. | Macrophage response during axonal regeneration in the axolotl central and peripheral nervous system | |
Costa et al. | Characterization of the circadian system in a Brazilian species of monkey (Callithrix jacchus): immunohistochemical analysis and retinal projections | |
Nicoll | Role of prolactin and placental lactogens in vertebrate growth and development | |
Yao et al. | Effect of mesenchymal stem cell-incorporated hydroxyapatite-collagen scaffold on tissue repair in acute spinal cord injury, and the mechanism involved | |
Van Aswegen et al. | The oesophagus and stomach of the African elephant: a histological, immunocytochemical and immunofluorescence study | |
CA1329122C (en) | Prevention of bovine respiratory disease complex in cattle by administration of interferon | |
Roubos et al. | Quantitative ultrastructural tannic acid study of the relationship between electrical activity and peptide secretion by the bag cell neurons of Aplysia californica |